Edition:
United Kingdom

Incyte Corp (INCY.OQ)

INCY.OQ on NASDAQ Stock Exchange Global Select Market

66.25USD
14 Dec 2018
Change (% chg)

$-1.04 (-1.55%)
Prev Close
$67.29
Open
$66.61
Day's High
$67.63
Day's Low
$65.66
Volume
506,852
Avg. Vol
561,281
52-wk High
$102.60
52-wk Low
$58.33

Chart for

About

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib). JAKAFI... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $24,161.52
Shares Outstanding(Mil.): 210.65
Dividend: --
Yield (%): --

Financials

  INCY.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -0.78 -- --
ROI: -11.99 9.01 14.96
ROE: -23.24 10.15 16.52

BRIEF-Incyte's Mid-stage Geometry Mono-1 Trial Of Investigational Medicine Capmatinib Shows Positive Results

* PHASE 2 GEOMETRY MONO-1 TRIAL OF INVESTIGATIONAL MEDICINE CAPMATINIB SHOWS POSITIVE RESULTS IN PATIENTS WITH MET-MUTATED ADVANCED NSCLC

19 Oct 2018

Earnings vs. Estimates